{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:00:13Z","timestamp":1790830813570,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,9,28]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Metastatic spread remains the leading cause of death in Nasopharyngeal\nCarcinoma (NPC); however, the role of mitochondrial homeostasis in this process remains\nlargely unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study aims to identify key genes associated with mitochondrial homeostasis and\nNPC metastasis, and to further explore their potential regulatory mechanisms, correlations with\nthe immune microenvironment, and prognostic values.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Focusing on metastasis- and mitochondrial homeostasis-related genes (MMHRGs),\nwe sequentially conduct screening for hub genes, construct regulatory networks, predict drug\nbinding, explore correlations with immunity and prognosis, and perform in vitro functional verification.\nCandidate hub genes were prioritized using LASSO regression combined with Random\nForests. Putative druggable compounds targeting these genes were identified through the Drug\nGene Interaction Database (DGIdb) and further examined by molecular docking. Immune infiltration\nand Tumor Immune Dysfunction and Exclusion (TIDE) analyses were performed to characterize\nthe tumor immune microenvironment and predict immunotherapy response. A prognostic\nnomogram incorporating these genes was developed, and its predictive accuracy was assessed\nusing time-dependent ROC curve analysis. Finally, the functional roles of the hub genes\nwere experimentally validated in NPC cell lines using wound-healing assays and transmission\nelectron microscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A mitochondrial homeostasis-related gene signature, highlighted by four hub genes\n(FKBP4, ATN1, CDKAL1, GPR25), was identified in NPC metastasis. These genes were\nembedded within extensive post-transcriptional and transcriptional regulatory networks (ceRNA,\nRNA-binding proteins, TFs, PPIs) to deeply illustrate the molecular mechanism in NPC.\nMolecular docking revealed SAR260301 with high binding affinity to FKBP4, suggesting potential\nbinding clues. Consensus clustering stratified NPC into two subtypes (Cluster_A\/B), with\nCluster_B showing enhanced immune checkpoint expression and TIDE-based features. A prognostic\nmodel incorporating HNMT, TAGLN3, CSF2RA, and LYZ demonstrated high predictive\naccuracy for NPC with AUC values of 0.854, 0.860, and 0.920 for 1-, 2-, and 3-year overall survival\nin the training cohort, and 0.778, 0.914, and 0.846 in the internal validation cohort. Crucially,\nfunctional validation showed that overexpression of GPR25 or knockdown of ATN1, CDKAL1,\nor FKBP4 significantly inhibited NPC cell migration and disrupted mitochondrial morphology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The study demonstrated mitochondrial homeostasis-related genes- FKBP4, ATN1,\nCDKAL1, and GPR25 as candidate hub genes in NPC metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study identified four novel mitochondrial homeostasis-associated hub genes\ninvolved in NPC metastasis, established a mitochondria-based molecular subtyping scheme, and\nprovided preliminary prognostic biomarkers and potential therapeutic targets for future mechanistic\nand translational investigations of metastatic NPC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673481654260903105403","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:44:21Z","timestamp":1790829861000},"source":"Crossref","is-referenced-by-count":0,"title":["Bioinformatics Identification and Functional Validation of Mitochondrial Homeostasis-Related Genes in Nasopharyngeal Carcinoma Metastasis"],"prefix":"10.2174","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4177-8380","authenticated-orcid":true,"given":"Zhen","family":"Guo","sequence":"first","affiliation":[{"name":"Hunan Provincial Key Laboratory of the Fundamental and Clinical Research on Functional Nucleic Acid, The First Clinical College, The First Affiliated Hospital of Changsha Medical University, Changsha Medical University, Changsha, 410219, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2232-4634","authenticated-orcid":true,"given":"BinSheng","family":"He","sequence":"additional","affiliation":[{"name":"Hunan Provincial Key Laboratory of the Fundamental and Clinical Research on Functional Nucleic Acid, The First Clinical College, The First Affiliated Hospital of Changsha Medical University, Changsha Medical University, Changsha, 410219, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4875-5149","authenticated-orcid":true,"given":"DanFeng","family":"Cao","sequence":"additional","affiliation":[{"name":"Hunan Provincial Key Laboratory of the Fundamental and Clinical Research on Functional Nucleic Acid, The First Clinical College, The First Affiliated Hospital of Changsha Medical University, Changsha Medical University, Changsha, 410219, China"},{"name":"Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha 410219, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673481654260903105403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258862\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673481654260903105403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:45:36Z","timestamp":1790829936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258862\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673481654260903105403","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}